Crispy Chip Sandwich and Process of Producing a Sandwich Product
A food product comprising a multilayer cookie or snack having outer layers formed from a crispy type edible food product such as a potato chip or corn chip, etc. with an intermediate marshmallow layer being in contact with the inner surface of each crispy chip and one or more filler substances.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6147250 | Compounds and methods for the inhibition of the expression of VCAM-1 This invention is in the area of methods and compositions for the inhibition of the expression of VCAM-1 and, in particular, for the treatment of diseases mediated by VCAM-1, including cardiovascular and inflammatory diseases.... | 11/14/2000 |
| 6121319 | Monoesters of probucol for the treatment of cardiovascular and inflammatory disease This invention is a method and composition for the inhibition of VCAM-1, and in particular for the treatment of cardiovascular or inflammatory disease, including atherosclerosis, that includes the administration of an effective amount of an ester of probu... | 09/19/2000 |
| 6071922 | Synthesis, anti-human immunodeficiency virus, and anti-hepatitis B virus activities of 1,3-oxaselenolane nucleosides A method and composition for the treatment of HIV infection, HBV infection, or abnormal cellular proliferation in humans and other host animals is disclosed that includes the administration of an effective amount of a 1,3-oxaselenolane nucleoside or a pha... | 06/06/2000 |
| 6020369 | Method compositions and apparatus for treating and preventing respiratory viral infections Respiratory viral infections may be effectively prevented or treated by administering an aerosol spray comprising a polyoxometalate to the lungs.... | 02/01/2000 |
| 5990093 | Treating HBV with phospholipid prodrugs of ଲ-L-2',3'-dideoxyadenosine 5'-monophosphate A method for treating HBV infections comprising administering a 5'-phospholipid prodrug of ଲ-L-2',3'-dideoxyadenosine 5'-monophosphate.... | 11/23/1999 |
| 5990341 | Diastereoselective synthesis hydroxyethylene dipeptide isosteres A process for the synthesis of hydroxyethylene dipeptide isosteres from -N,N-di(protected)amino(alkyl or substituted alkyl) methyl ketones that can be efficiently carried out on an industrial scale. The process proceeds with excellent diastereosele... | 11/23/1999 |
| 5925643 | Enantiomerically pure ଲ-D-dioxolane-nucleosides A method and composition for the treatment of humans infected with HIV that includes the administration of an HIV treatment amount of an enantiomerically pure ଲ-D-dioxolanyl purine nucleoside of the formula: ##STR1## wherein R is OH, Cl, N... | 07/20/1999 |
| 5914400 | Method and compositions for the synthesis of BCH-189 and related compounds The present invention relates to a method of preparing BCH-189 and various analogs of BCH-189 from inexpensive precursors with the option of introducing functionality as needed. This synthetic route allows the stereoselective preparation of the biological... | 06/22/1999 |
| 5914331 | Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane A method and composition for the treatment of HIV and HBV infections in humans is disclosed that includes administering an effective amount of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane, a pharmaceutically acceptable derivative thereof, incl... | 06/22/1999 |
| 5905070 | 5--Caboxamido or 5--fluoro!--2', 3'--unsaturated or 3'--modified!--pyrimidine nucleosides A method and composition for the treatment of HIV and HBV infections in humans and other host animals is disclosed that includes the administration of an effective amount of a 5-carboxamido or 5-fluoro!-2',3'-dideoxy-2',3'-didehydro-pyrimidine nucleosid... | 05/18/1999 |
| 5892025 | Method of resolution and antiviral activity of 1,3-oxathiolane nucleoside enantiomers A process for the resolution of a racemic mixture of nucleoside enantiomers that includes the step of exposing the racemic mixture to an enzyme that referentially catalyzes a reaction in one of the enantiomers. The nucleoside enantiomer (-)-2-hydroxy... | 04/06/1999 |
| 5877203 | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases Dithiocarboxylates, and in particular, dithiocarbamates, block the induced expression of the endothelial cell surface adhesion molecule VCAM-1, and are therefor useful in the treatment of cardiovascular disease, including atherosclerosis, post-angioplasty... | 03/02/1999 |
| 5872107 | Treatment of urogenital cancer with boron neutron capture therapy Methods and compositions for treating urogenital tumors, and in particular, cancer of the prostate, bladder, and kidney, with BCNT, are disclosed. Any boron-containing compound that is sufficiently lipophilic to pass through the appropriate urogenital mem... | 02/16/1999 |
| 5852027 | Antiviral 1,3-dioxolane nucleoside analogues This invention includes the compounds 2'-deoxy-5-fluoro-3'-oxacytidine, (-)-2'-deoxy-5-fluoro-3'-oxacytidine, and (+)-2'-deoxy-5-fluoro-3+-oxacytidine, and pharmaceutically acceptable salts thereof for use in medical therapy, for example for the treatment... | 12/22/1998 |
| 5846959 | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases A method for the treatment of cardiovascular diseases and noncardiovascular inflammatory diseases that are mediated by VCAM-1 is provided that includes the removal, decrease in the concentration of, or prevention of the formation of oxidized polyunsaturat... | 12/08/1998 |
| 5834474 | Enantiomerically pure B--D--dioxolane nucleosides with selective anti-hepatitus B virus activity A method and composition for the treatment of humans infected with HBV that includes the administration of an HBV treatment amount of a ଲ-dioxolanyl purine nucleoside of the formula: ##STR1## wherein R is OH, Cl, NH2, or H, or a phar... | 11/10/1998 |
| 5830898 | Enantiomerically pure ଲ-di-dioxolane-nucleosides with selective anti-hepatitis B virus activity A method and composition for the treatment of humans infected with HBV that includes the administration of an HBV treatment amount of a ଲ-dioxolanyl purine nucleoside of the formula: ##STR1## wherein R is OH, Cl, NH2, or H, or a phar... | 11/03/1998 |
| 5827727 | Method of resolution of 1,3-oxathiolane nucleoside enantiomers A process for the resolution of a racemic mixture of nucleoside enantiomers that includes the step of exposing the racemic mixture to an enzyme that preferentially catalyzes a reaction in one of the enantiomers. The nucleoside enantiomer (-)-2-hydrox... | 10/27/1998 |
| 5821260 | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases Dithiocarboxylates, and in particular, dithiocarbamates, block the induced expression of the endothelial cell surface adhesion molecule VCAM-1, and are therefor useful in the treatment of cardiovascular disease, including atherosclerosis, post-angioplasty... | 10/13/1998 |
| 5814639 | Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds The present invention relates to a method of preparing the antiviral compounds 2'-deoxy-5-fluoro-3'thiacytidine (FTC) and various prodrug analogues of FTC from inexpensive precursors with the option of introducing functionality as needed; methods of using... | 09/29/1998 |
| 5811449 | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases A method for the treatment of cardiovascular diseases and noncardiovascular inflammatory diseases that are mediated by VCAM-1 is provided that includes the removal, decrease in the concentration of, or prevention of the formation of oxidized polyunsaturat... | 09/22/1998 |
| 5807884 | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases A method for the treatment of cardiovascular diseases and noncardiovascular inflammatory diseases that are mediated by VCAM-1 is provided that includes the removal, decrease in the concentration of, or prevention of the formation of oxidized polyunsaturat... | 09/15/1998 |
| 5808040 | L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides A method for stabilizing an oligonucleotide by including a ଲ-L-2'-deoxy-2'-fluoro-arabinofuranosyl nucleoside at the 5'-terminus, the 3'-terminus, or in the interior of the oligonucleotide. The oligonucleotide can be used in the modulation of gene e... | 09/15/1998 |
| 5792787 | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases Dithiocarboxylates, and in particular, dithiocarbamates, block the induced expression of the endothelial cell surface adhesion molecule VCAM-1, and are therefor useful in the treatment of cardiovascular disease, including atherosclerosis, post-angioplasty... | 08/11/1998 |
| 5783596 | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases Dithiocarboxylates, and in particular, dithiocarbamates, block the induced expression of the endothelial cell surface adhesion molecule VCAM-1, and are therefor useful in the treatment of cardiovascular disease, including atherosclerosis, post-angioplasty... | 07/21/1998 |
| 5767122 | Enantiomerically pure ଲ-d-dioxolane nucleosides A method and composition for the treatment of humans infected with HIV that includes the administration of an HIV treatment amount of an enantiomerically pure ଲ-D-dioxolanyl purine nucleoside of the formula: ##STR1## wherein R is OH, Cl, N... | 06/16/1998 |
| 5750351 | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases A method for the treatment of cardiovascular diseases and noncardiovascular inflammatory diseases that are mediated by VCAM-1 is provided that includes the removal, decrease in the concentration of, or prevention of the formation of oxidized polyunsaturat... | 05/12/1998 |